Linda Ye

Linda Ye

Auto-generated profile, based on publicly available information

Linda Ye

Department of Surgery, David Geffen School of Medicine at UCLA , Los Angeles, California, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
MAMichael E. Abram
Michael E. Abram
RHRebecca M. Hluhanich
Rebecca M. Hluhanich
DGDerrick D. Goodman
Derrick D. Goodman
KAKristen N. Andreatta
Kristen N. Andreatta
NMNicolas A. Margot
Nicolas A. Margot
MMMichael D. Miller
Michael D. Miller
Elvitegravir (EVG) is an effective HIV-1 integrase (IN) strand transfer inhibitor (INSTI) in advanced clinical development. Primary INSTI resistance-associated mutations (RAMs) at six IN positions have been identified in HIV-1-infected patients failing EVG-containing regimens in clinical studies: T66I/A/K, E92Q/G, T97A, S147G, Q148R/H/K, and N155H. In this study, the effect of these primary IN mutations, alone and in combination, on susceptibility to the INSTIs EVG, raltegravir (RAL), and dolutegravir (DTG); IN enzyme activities; and viral replication fitness was characterized. Recombinant viruses containing the six most common mutations exhibited a range of reduced EVG susceptibility: 92-fold for Q148R, 30-fold for N155H, 26-fold for E92Q, 10-fold for T66I, 4-fold for S147G, and 2-fold for T97A. Less commonly observed primary IN mutations also showed a range of reduced EVG susceptibilities: 40- to 94-fold for T66K and Q148K and 5- to 10-fold for T66A, E92G, and Q148H. Some primary IN mutations exhibited broad cross-resistance between EVG and RAL (T66K, E92Q, Q148R/H/K, and N155H), while others retained susceptibility to RAL (T66I/A, E92G, T97A, and S147G). Dual combinations of primary IN mutations further reduced INSTI susceptibility, replication capacity, and viral fitness relative to either mutation alone. Susceptibility to DTG was retained by single primary IN mutations but reduced by dual mutation combinations with Q148R. Primary EVG RAMs also diminished IN enzymatic activities, concordant with their structural proximity to the active site. Greater reductions in viral fitness of dual mutation combinations may explain why some primary INSTI RAMs do not readily coexist on the same HIV-1 genome but rather establish independent pathways of resistance to EVG.

17 November 2021 in BJS Open
Verified
Journal Article
Open access
PDF file
LYLinda Ye
Linda Ye
CCChristopher P Childers
Christopher P Childers
MVMichael de Virgilio
Michael de Virgilio
RSRivfka Shenoy
Rivfka Shenoy
MMMichael A Mederos
Michael A Mederos
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
Background: Robotic ventral hernia repair (VHR) has seen rapid adoption, but with limited data assessing clinical outcome or cost. This systematic review compared robotic VHR with laparoscopic and open approaches. Methods: This systematic review was undertaken in accordance with PRISMA guidelines. PubMed, MEDLINE, Embase, and Cochrane databases were searched for articles with terms relating to ‘robot-assisted’, ‘cost effectiveness’, and ‘ventral hernia’ or ‘incisional hernia’ from 1 January 2010 to 10 November 2020. Intraoperative and postoperative outcomes, pain, recurrence, and cost data were extracted for narrative analysis. Results: Of 25 studies that met the inclusion criteria, three were RCTs and 22 observational studies. Robotic VHR was associated with a longer duration of operation than open and laparoscopic repairs, but with fewer transfusions, shorter hospital stay, and lower complication rates than open repair. Robotic VHR was more expensive than laparoscopic repair, but not significantly different from open surgery in terms of cost. There were no significant differences in rates of intraoperative complication, conversion to open surgery, surgical-site infection, readmission, mortality, pain, or recurrence between the three approaches. Conclusion: Robotic VHR was associated with a longer duration of operation, fewer transfusions, a shorter hospital stay, and fewer complications compared with open surgery. Robotic VHR had higher costs and a longer operating time than laparoscopic repair. Randomized or matched data with standardized reporting, long-term outcomes, and cost-effectiveness analyses are still required to weigh the clinical benefits against the cost of robotic VHR.

1 May 2021 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
LYLinda Ye
Linda Ye
ATAmber B. Tang
Amber B. Tang
RSRivfka Shenoy
Rivfka Shenoy
MMMichael A. Mederos
Michael A. Mederos
SMSelene S. Mak
Selene S. Mak
PSPaul S. Shekelle
Paul S. Shekelle

8 February 2018 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
LYLinda Ye
Linda Ye
LGLei Gu
Lei Gu
JCJoseph Caprioli
Joseph Caprioli
NPNatik Piri
Natik Piri

25 October 2020 in The American Surgeon™
Verified
Journal Article
Closed access
PDF file
RMRoxanne L. Massoumi
Roxanne L. Massoumi
NCNikhil Crain
Nikhil Crain
CZCatherine Zhu
Catherine Zhu
AMAlexandra Moore
Alexandra Moore
GOGabriel Oland
Gabriel Oland
AAArmen Aboulian
Armen Aboulian
Unplanned returns after ambulatory surgery pose a burden to patients and health care providers alike. We hypothesized that a postoperative phone call by a physician would decrease avoidable returns to urgent care (UC) or the emergency department (ED) in the week after anorectal (AR), laparoscopic cholecystectomy (LC), inguinal hernia repair (IHR), and umbilical hernia repair (UHR) operations. A retrospective analysis from 1/2011 to 12/2015 across 14 Kaiser hospitals was conducted to determine baseline UC/ED return rates of patients pre-call. Between 10/2017 and 06/2019, physicians placed phone calls to patients within postoperative days (PODs) 1-4. The cohorts were compared using chi-squared analysis with significance determined at P < .05. In total, 276 patients received a call, with the majority placed on PODs 1-3. There were no statistically significant differences in return rates between the pre- and post-call groups. All of the AR, 50.0% of LC, 66.7% of IHR, and 50.0% of UHR patients returned prior to phone call placement. Our data indicate that a physician phone call does not help in decreasing UC/ED returns. However, it is noteworthy that many of the returns occurred pre-call placement. Future directions should be aimed at placing earlier postoperative phone calls.

1 April 2020 in Annals of Surgery
Verified
Journal Article
Closed access
LYLinda Ye
Linda Ye
OHO. Joe Hines
O. Joe Hines